The HealthWell Foundation showcases its significant oncology fund programs at the ASCO Annual Meeting, aimed at assisting cancer patients with financial support for treatments.

A recent study reveals that cancer patients nearing the end of life face a higher risk of bleeding than clotting, raising critical questions about antithrombotic therapies.

Adelance supports cancer patients in Thailand by donating 100 wigs to improve their quality of life, marking a meaningful CSR initiative.

A collaborative study by Nihon University and Kaltec reveals titanium dioxide photocatalysis effectively decreases febrile neutropenia rates in cancer patients.

In light of funding cuts in cancer research, the Radical Remission Workshop empowers patients to take their health into their own hands, backed by Harvard research.

Recent studies highlight a concerning trend where cancer patients exhibit a significantly higher likelihood of harboring antimicrobial resistant infections compared to non-cancer patients.

Endevica Bio has launched a Phase 2 clinical trial for TCMCB07, a peptide aimed at preventing weight loss in cancer patients undergoing chemotherapy. This is a significant advancement for treatment options.